Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

29452 ARTÍCULOS , VIENDO DEL 301 AL 315

Amyloidogenic amylin signaling links diabetes to dementia pathogenesis

Despa F, Lashley T.

Trends Pharmacol Sci. 2026 Sep;47(9):955-958. doi: 10.1016/j.tips.2026.07.009. Epub 2026 Aug 10.

Brain organoids in Alzheimer disease and related tauopathies: Challenges and opportunities for translational readiness

Guruacharya A, Hartung T, Souza Dos Reis R, Moreira NCDS, Attisano L, Bolognin S, Iqbal K, Rajbanshi B.

Stem Cell Reports. 2026 Sep 8;21(9):103051. doi: 10.1016/j.stemcr.2026.103051. Epub 2026 Aug 20.

Icariside II in Neurological Disorders: Mechanistic Insights Into Alzheimer's Disease, Cerebral Ischemia and Parkinson's Disease

Solanki A, Sharma K, Jain J, Singh NK, Krishnamurthy PT.

J Biochem Mol Toxicol. 2026 Sep;40(9):e71093. doi: 10.1002/jbt.71093.

Decoding Synaptic Diversity: Molecular Architectures, Phase Transitions, and Shared Postsynaptic Failure in Alzheimer's and Parkinson's Disease

Cipriano GL, Anchesi I, Floramo A, Argento V, Spinelli S, Astorino MF, Calabrò M, Artimagnella O.

Cells. 2026 Aug 9;15(16):1433. doi: 10.3390/cells15161433.

From adolescence to Alzheimer's: a neurodevelopmental lifespan model of cognitive vulnerability

Pasricha S, Kaur S.

Neurol Sci. 2026 Aug 26;47(9):737. doi: 10.1007/s10072-026-09304-w.

The Tryptophan-Kynurenine Pathway as a Key Mediator of the Gut-Brain Axis in Depression and Alzheimer's Disease

Procopciuc LM, Hangan AC, Gog-Bogdan S, Lucaciu RL.

Int J Mol Sci. 2026 Sep 12;27(18):8122. doi: 10.3390/ijms27188122.

Reframing Alzheimer's Disease Through a Redox-Metabolic Framework

Velázquez De Castro-Bono A, Castro-Luna G, Guil-Guerrero JL.

Int J Mol Sci. 2026 Sep 17;27(18):8294. doi: 10.3390/ijms27188294.

Brain-Targeting siRNA Delivery to Tackle Alzheimer's Disease

Yang Q, Chen Z, Zhu J, Chai T, Tang F, Fan M, Li Y, Chen S, Liu Y, Zheng M.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2026 Sep-Oct;18(5):e70076. doi: 10.1002/wnan.70076.

The Ocular Microbiome and Alzheimer's Disease: Emerging Insights

Mishra SK, Ozkan J, Su F, Kim WS, Willcox M, Fu Y.

Cells. 2026 Sep 1;15(17):1590. doi: 10.3390/cells15171590.

Border-Associated Macrophage Migrasomes in Alzheimer's Disease: An Emerging Aβ-Senescence-Microglia Axis?

Chmiel J, Kopańska M.

Cells. 2026 Sep 16;15(18):1671. doi: 10.3390/cells15181671.

Pharmacotherapy for Alzheimer's Disease and Dementias in Long-Term Care: A Real-World EHR Study

Saumur TM, Ashraf H, Mathers KE, Wagner B.

J Am Med Dir Assoc. 2026 Sep;27(9):106293. doi: 10.1016/j.jamda.2026.106293. Epub 2026 Jul 3.

Mitophagy deficiency and calcium dyshomeostasis underlying the pathogenesis and progression of Alzheimer's disease

Meng G, Cai L, Mo Z, An S, Sun W, Shen P, Xie Y.

J Alzheimers Dis. 2026 Sep;113(1):16-35. doi: 10.1177/13872877261465779. Epub 2026 Jul 11.

Nanomedicine targeting neuroinflammatory pathways in Alzheimer's disease: a new frontier in inflammopharmacology

Kaushik S, Fatima JE, Raheem A, Barbhuiya MA, Thirupathi AT, Singh LP, Khan PA, Aparna TN, Pramanik S, Shahid MAA.

Inflammopharmacology. 2026 Aug;34(8):5365-5404. doi: 10.1007/s10787-026-02329-9. Epub 2026 Jul 17.

Rational drug design for Alzheimer's disease: from approved therapies to next-generation clinical candidates and AI-guided innovation

Saffour S, Gul TS, Gul HI.

Future Med Chem. 2026 Sep;18(17):2425-2443. doi: 10.1080/17568919.2026.2714022. Epub 2026 Aug 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias